Condition
Cutaneous Mastocytosis
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed3
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07142473RecruitingPrimary
Mastocytosis From Pediatric Age to Adulthood: Local Registry of Cutaneous and Systemic Mastocytosis
NCT04377828Not ApplicableUnknownPrimary
Improvement of Pigmented Skin Lesions in Patients With Mastocytosis After Performing 2 Sessions of Pigment Laser
NCT02761473Completed
Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations
NCT03632811CompletedPrimary
Adaptation of the Questionnaire "Regarding Patient's Quality of Life With Mastocytosis" in the French Language
NCT00457288Phase 2CompletedPrimary
Efficacy and Safety of TF002 in Cutaneous Mastocytosis
Showing all 5 trials